The Future of Healthcare: “Kill bacteria with robots and not antibiotics that create antibiotic resistant germs” with Xenex CEO Morris Miller

As a part of my series about “The Future of Healthcare” I had the pleasure of interviewing Morris Miller. Under Morris Miller’s leadership, Xenex has become a world leader in automated room disinfection. Through the use of xenon technology and innovative hospital disinfection protocols, the company is helping healthcare facilities achieve significant infection reduction results. As CEO, Morris is responsible for the company’s overall business strategy and oversight of day-today operations. Originally from San Antonio, Morris is a graduate of the Dedman School of Law at Southern Methodist University, The University of Texas at Austin, and Phillips Exeter Academy. He is the co-founder of Tectonic Ventures, formed in 2016 to advice founders, start-ups and established technology companies. Prior to co-founding Tectonic Ventures, Morris founded Sequel Ventures and Cutstone Ventures, which invests in/acts as an advisor to numerous start-ups such as Inventables, Adometry, and Golfballs.com. He started Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM, and he was also the co-founder and President/CEO of Rackspace (NYSE: RAX). Morris is a member of APIC and BioMed SA.